Original Research

Using Telehealth to Increase Lung Cancer Screening Referrals for At-Risk Veterans in Rural Communities

Author and Disclosure Information

 

References

Limitations

This was a small, single site project composed of predominantly White male rural veterans participating in a smoking cessation program associated with a VA facility.26,27 It is not clear whether similar outcomes would be observed in at-risk veterans who do not participate in a smoking cessation program or in more diverse communities. We were unable to contact 40% of LCS-eligible rural veterans by telephone. Twelve veterans reached by telephone declined to participate in LCS without providing a reason, and only 19 of 68 eligible veterans (28%) underwent LDCT screening during the 4-month telehealth intervention. The reasons underlying this overall low accrual rate and whether rural veterans prefer other means of personal communication regarding LCS were not determined. Lastly, generalizability of our initial observations to other veterans living in rural communities is limited because the project was conducted only in rural northern Wisconsin and the Upper Peninsula of Michigan.

Conclusions

At-risk rural veterans may be willing to participate in a centralized LCS program at a regional VA medical facility when contacted and coordinated using telehealth modalities. These findings offer support for future prospective, multisite, VA telehealth-based studies to be conducted in rural areas. The results of this project also suggest that telehealth intervention could increase referrals of at-risk rural veterans to the closest centralized LCS program located at a regional VA medical facility.

Pages

Recommended Reading

New mRNA Vaccines in Development for Cancer and Infections
AVAHO
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
AVAHO
LDCT Lung Cancer Screening Finds Undiagnosed Pulmonary Comorbidities in High-Risk Population
AVAHO
Obesity and Cancer: Untangling a Complex Web
AVAHO
‘Groundbreaking’ Trial Shows Survival Benefits in Lung Cancer
AVAHO
One Patient Changed This Oncologist’s View of Hope. Here’s How.
AVAHO
New Trials in Lung Cancer: Could Your Patients Benefit?
AVAHO
MUC-1 vaccine associated with notable overall survival rates in breast cancer
AVAHO
Urticaria Linked to Higher Cancer Risk, Study Finds
AVAHO
Should Cancer Trial Eligibility Become More Inclusive?
AVAHO